BetterWay Enters Into an Affiliation Agreement with UT Austin for Capillary Blood Collection

AUSTIN, TX / ACCESS Newswire / March 31, 2026 / BetterWay(TM) blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, today announced ...
Seeking Alpha

BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J., Dec. 7, 2023 ...
Nasdaq

Babson, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings

AUSTIN, Texas and FRANKLIN LAKES, N.J., May 11, 2022 /PRNewswire/ -- Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading ...
Los Angeles Times

New Finger Prick Blood Test Rivals Brain Scans for Alzheimer’s Diagnosis

Capillary blood tests measure p-tau217, GFAP, and NfL without strict temperature controls or immediate centrifugation. Primary care physicians currently have a diagnostic accuracy of ~61% for ...
Seeking Alpha

BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations

FRANKLIN LAKES, N.J. and AUSTIN, Texas, Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, and Babson Diagnostics, a science-first ...
Business Wire

Babson Diagnostics’ BetterWay™ Blood Testing Service Achieves Critical Milestone Ahead of Commercialization

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...
Business Insider

BD Gets FDA 510(k) Clearance For Fingertip Blood Collection Device

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood ...